Prism vs. Prozac: A Novel Approach to the Amelioration of Anxiety
Poster Presentation at the Anxiety Disorders of America Annual Meeting, Arlington, VA, April 2012
The objective of this study is to utilize validated survey instruments and other metrics to quantify the reduction of anxiety (as well as dizziness and headache) resulting from prismatic lens intervention in VH patients with prominent anxiety.
View the ADAA poster (PDF)
Read the ADAA Poster Merged with figures (PDF)